Inventor · disambiguated record
Daniel Korr
Also filed as: KORR DANIEL
5 granted patents·14 pending applications·55 citations·filing 2008–2024
75Inventor score
Top patents by PatentIndex Score
19 records- 0194US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0290US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 0374US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 0471US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 0560US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 0660US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0756US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 0854US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 0951US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 1048US12403135B24H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2020·Granted Sep 2, 2025·0 cites·16 claims
- 1146US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 1246US2008268041A1Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 1346US2009029954A1Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogenHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 1446US2008261929A1Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 1546US2008261933A1Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 1643US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 1739US2014288069A1Amino-substituted imidazopyridazines as mknk1 kinase inhibitorsEIS KNUT·Filed 2012·Application pending·0 cites
- 1837US2020123147A1Thiazole compounds useful as prmt5 inhibitorsBAYER AG·Filed 2018·Application pending·0 cites
- 1934US2008311594A1USE OF FIBROBLAST GROWTH FACTOR 7 (Fgf7) AND OF THE RECEPTOR Fgfr2b AS BIOMARKERSHOFFMAN JENS·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Korr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →